Please login to the form below
Elliott Levy joins Amgen from BMS
He is appointed senior VP, global development
Dr Elliott Levy has left his role at Bristol-Myers Squibb to join Amgen as senior VO, global development.
Levy was most recently senior VP and head of specialty development at BMS, where he spent 17 years.
During this time he served in a number of senior roles including head of global pharmacovigilance and epidemiology.
“Elliott brings a wealth of development and leadership experience to his new role at Amgen,” said Dr Sean Harper, executive VP of R&D at Amgen.
“His track record shows his success in leading major clinical development programmes, and we're confident that he will help Amgen to serve patients by advancing the large number of potential new medicines in our late-stage pipeline.”
Featured jobs
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Global Business Development Director – Health Education
-
excellent commission
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Medical Writer
-
Salary TBC
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Senior Medical Writer
-
Salary TBC
-
Account Manager / Account Director
-
Competative
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- FDA expecting boom in cell and gene therapies
- Moving annual total (MAT)
- AZ’s Sean Bohen to exit after business overhaul; report
- FDA moves into crisis mode as shutdown drags on
- Lucid Group prepare for a transformative year with the appointment of a new Director of Corporate Development
PMHub
Top Pharma News
TopPharmaNews.com is a global pharma magazine dedicated to delivering fresh news to society. The team at the TopPharmaNews.com cater non-biased,...
Latest intelligence
- NHS regional footprints
- What to expect from 2019...
- Not another weight-loss ad
- Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
- China’s clinical trial shake-up
- As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Quick links
Infographics
